Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA. Margot N, Pennetzdorfer N, Naik V, Rhee M, et al. Antivir Ther 2023;28:13596535231220754.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Margot N, Pennetzdorfer N, Naik V, Rhee M, et al. Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA. Antivir Ther 2023;28:13596535231220754.
PMID: 38085652